Arcturus Therapeutics controller resigns effective March 15, 2024; assistant controller promoted

Arcturus Therapeutics Holdings Inc.

Keith C. Kummerfeld, SVP of Finance and Corporate Controller, resigns effective March 15, 2024 to pursue another opportunity.
Joseph Roberts, formerly Assistant Controller, promoted to Controller of the Company.
Resignation is not due to any disagreement with the Company's operations, policies, or practices.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Joseph Roberts

Controller

ARCT · Arcturus Therapeutics Holdings Inc.

Filed: February 23, 2024, 6:59 PM ET

Joseph Roberts, formerly the Company’s Assistant Controller, has been promoted to Controller of the Company.

Departed

Keith C. Kummerfeld

Senior Vice President of Finance and Corporate Controller

ARCT · Arcturus Therapeutics Holdings Inc.

Effective: 2024-03-15
Successor: Joseph Roberts
Filed: February 23, 2024, 6:59 PM ET

Keith C. Kummerfeld, Senior Vice President of Finance and Corporate Controller of Arcturus Therapeutics Holdings Inc. (the “Company” or “Arcturus”), informed the Company that he will resign from his position with the Company, effective March 15, 2024, to pursue another opportunity.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Joseph Roberts changed role as Controller at Arcturus Therapeutics Holdings Inc..

Action: promoted
Role: Controller

Exact text from the filing

Joseph Roberts, formerly the Company’s Assistant Controller, has been promoted to Controller of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Keith C. Kummerfeld resigned as Senior Vice President of Finance and Corporate Controller at Arcturus Therapeutics Holdings Inc..

Action: resigned
Role: Senior Vice President of Finance and Corporate Controller

Exact text from the filing

Keith C. Kummerfeld, Senior Vice President of Finance and Corporate Controller of Arcturus Therapeutics Holdings Inc. (the “Company” or “Arcturus”), informed the Company that he will resign from his position with the Company, effective March 15, 2024, to pursue another opportunity.

View on SEC.gov

Arcturus Therapeutics Holdings Inc. filing history →

Source: SEC EDGAR

accession 0001193805-24-000264

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.